These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 18206700

  • 1. Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms.
    Becker K, El-Faddagh M, Schmidt MH, Esser G, Laucht M.
    J Pediatr; 2008 Feb; 152(2):263-9. PubMed ID: 18206700
    [Abstract] [Full Text] [Related]

  • 2. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
    Laucht M, Skowronek MH, Becker K, Schmidt MH, Esser G, Schulze TG, Rietschel M.
    Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
    [Abstract] [Full Text] [Related]

  • 3. Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors.
    Kahn RS, Khoury J, Nichols WC, Lanphear BP.
    J Pediatr; 2003 Jul; 143(1):104-10. PubMed ID: 12915833
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
    Kim JW, Kim BN, Cho SC.
    J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
    [Abstract] [Full Text] [Related]

  • 7. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA, Johnson KA, Barry E, Mulligan A, Hawi Z, Gill M, Robertson I, Chambers CD.
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Attention-deficit/hyperactivity disorder (ADHD) association with the DAT1 core promoter -67 T allele.
    Ohadi M, Shirazi E, Tehranidoosti M, Moghimi N, Keikhaee MR, Ehssani S, Aghajani A, Najmabadi H.
    Brain Res; 2006 Jul 26; 1101(1):1-4. PubMed ID: 16782077
    [Abstract] [Full Text] [Related]

  • 10. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
    Bellgrove MA, Hawi Z, Kirley A, Gill M, Robertson IH.
    Neuropsychologia; 2005 Jul 26; 43(13):1847-57. PubMed ID: 16168728
    [Abstract] [Full Text] [Related]

  • 11. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.
    van der Meulen EM, Bakker SC, Pauls DL, Oteman N, Kruitwagen CL, Pearson PL, Sinke RJ, Buitelaar JK.
    J Child Psychol Psychiatry; 2005 Oct 26; 46(10):1074-80. PubMed ID: 16178931
    [Abstract] [Full Text] [Related]

  • 12. Association of the risk allele of dopamine transporter gene (DAT1*10) in Omani male children with attention-deficit hyperactivity disorder.
    Simsek M, Al-Sharbati M, Al-Adawi S, Ganguly SS, Lawatia K.
    Clin Biochem; 2005 Aug 26; 38(8):739-42. PubMed ID: 15993876
    [Abstract] [Full Text] [Related]

  • 13. Dopamine transporter genotype influences the physiological response to medication in ADHD.
    Gilbert DL, Wang Z, Sallee FR, Ridel KR, Merhar S, Zhang J, Lipps TD, White C, Badreldin N, Wassermann EM.
    Brain; 2006 Aug 26; 129(Pt 8):2038-46. PubMed ID: 16760197
    [Abstract] [Full Text] [Related]

  • 14. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
    Auerbach JG, Atzaba-Poria N, Berger A, Landau R, Arbelle S, Raz Y, Ebstein R.
    Psychiatr Genet; 2010 Aug 26; 20(4):160-5. PubMed ID: 20421851
    [Abstract] [Full Text] [Related]

  • 15. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H, Henríquez H M, Carrasco Ch X, Rothhammer A P, Llop R E, Aboitiz F, Rothhammer E F.
    Rev Med Chil; 2008 Jun 26; 136(6):719-24. PubMed ID: 18769827
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early risk factors for hyperactivity-impulsivity and inattention trajectories from age 17 months to 8 years.
    Galéra C, Côté SM, Bouvard MP, Pingault JB, Melchior M, Michel G, Boivin M, Tremblay RE.
    Arch Gen Psychiatry; 2011 Dec 26; 68(12):1267-75. PubMed ID: 22147844
    [Abstract] [Full Text] [Related]

  • 18. Relations between multi-informant assessments of ADHD symptoms, DAT1, and DRD4.
    Gizer IR, Waldman ID, Abramowitz A, Barr CL, Feng Y, Wigg KG, Misener VL, Rowe DC.
    J Abnorm Psychol; 2008 Nov 26; 117(4):869-80. PubMed ID: 19025233
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [ADHD and attachment processes: are they related?].
    Franc N, Maury M, Purper-Ouakil D.
    Encephale; 2009 Jun 26; 35(3):256-61. PubMed ID: 19540412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.